PharmaBlock Sciences (Nanjing) (300725.SZ) Earnings Analysis

PharmaBlock Sciences (Nanjing) (300725.SZ) next reports earnings on 2026-08-11. Last quarter (2025-04-28) it missed with EPS 0.18 CNY vs 0.36 CNY est (-50%). It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E 42.64.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 300725.SZ next report earnings?

Next earnings date2026-08-11
Consensus EPS estimaten/a
Revenue estimaten/a

300725.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-04-280.18 CNY0.36 CNY-50%Miss
2024-08-160.2475 CNY0.34 CNY-27.2%Miss

Beat rate: 0/2 (0%) over reported quarters with consensus data.

300725.SZ valuation and analyst view

Trailing P/E42.64
Trailing EPS0.84487 CNY
Price / book1.64
Dividend yield0.72%
Market cap7.90B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is PharmaBlock Sciences (Nanjing) (300725.SZ)'s next earnings date?

PharmaBlock Sciences (Nanjing) is next scheduled to report on 2026-08-11.

Did 300725.SZ beat earnings last quarter?

In its 2025-04-28 report, 300725.SZ posted EPS of 0.18 CNY versus a 0.36 CNY estimate — a miss of 50%.

What is 300725.SZ's earnings track record?

Over the last 2 reported quarters with consensus data, 300725.SZ beat estimates 0 times (0%).

What is 300725.SZ's current P/E ratio and EPS?

300725.SZ trades at a trailing P/E of 42.64 on trailing EPS of 0.8448740484292631 CNY.

What do analysts rate 300725.SZ?

300725.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.